BB-10901

· ImmunoGen, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for BB-10901, covering 2012-06-20 to 2015-03-26. Get the full timeline:

Most recent: Clinical Trial Update: BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors [Phase 1]